Clinical Trials in North Carolina

Showing 2121-2140 of 17,526 trials

Janus Feasibility Study

NCT03985527

The purpose of this feasibility study is to assess whether an alternative transvenous lead location affects respiration and airway physiology during a commercial remedē® System or commercial transvenous cardiac device (de novo pacemaker or implantable cardiac defibrillator) implant procedure.

Sleep Apnea Syndromes

Respicardia, Inc.29 participantsStarted Jan 2020

Winston-Salem, North Carolina, United States • Columbus, Ohio, United States • Bryn Mawr, Pennsylvania, United States

RECRUITINGNA41 miles

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

NCT06983041

The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In addition, the safety, mycological cure rates, the speed and efficacy of symptom resolution, vaginal hyphae and polymorphonuclear (PMN) scores, and Quality-of-Life (QoL) parameters will be determined.

Vulvovaginal Candidiasis (VVC)Yeast Vaginitis

Coologics, Inc55 participantsStarted May 2025

Jacksonville, Florida, United States • Miami, Florida, United States • Smyrna, Georgia, United States +7 more locations

Janus Feasibility Study

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Find Trials by Condition in North Carolina

Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

PK/PD of Digoxin in Infants With SVHD

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

GDNF Gene Therapy for Multiple System Atrophy

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)